MEA HbA1c Testing Market

The Middle East and Africa HbA1c Testing market is anticipated to grow at 9.58% CAGR from 2023 to 2028. The Middle East and Africa market was estimated to be valued at USD 131.50 Million in 2023 and is expected to reach USD 207.76 Million by 2028.

Hemoglobin A1C (HbA1c) is a kind of hemoglobin that binds to glucose. The HbA1c test calculates the patient's average blood sugar level over the past two to three months. These tests are frequently combined with others to provide the best results.

The increase in the number of diabetes research organizations and associations is one of the primary reasons anticipated to boost the growth and demand of the HbA1c testing market in this region. Furthermore, an increase in key player initiatives and the prevalence of diabetes are projected to contribute to the Middle East and Africa market's growth over the forecast period.

Rising per capita disposable income and the development of healthcare infrastructure are driving the market's growth. In addition, the emergence of new therapeutic options is propelling the market ahead. Furthermore, medical tourism's rapid growth and increased demand for precise HbA1c level assessment are projected to drive the market forward. Furthermore, the growing senior population and the effects of a sedentary lifestyle and a poor diet are expected to propel the HbA1c testing market forward.

The testing equipment is quite expensive, and due to that, these technologies are less commonly employed in developing countries, restricting the expansion of the hemoglobin A1c testing market. In addition, limited indications for HbA1c tests and strict reimbursement policies are anticipated to hinder the market's growth in developing countries. At the same time, rising accuracy concerns among the populace may further limit the market's growth. The HbA1c standard range testing result could be erroneous due to interpretation discrepancies, restricting the expansion of the HbA1c assay market.

This research report on the Middle East and Africa HbA1c Testing market has been segmented and sub-segmented into the following categories.

By Technology:

• Ion-Exchange HPCL             
• Enzymatic Assay   
• Affinity Binding Chromatography  
• Turbidimetric Inhibition Immunoassay       
• Other       

By Type:

• Hand-Held Devices               
• Bench Top Devices   

By End User:

• Hospital    
• Home Care              
• Diagnostic laboratory          
• Research Institutions

By Country:

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Geographically, the MEA accounted for a moderate global market in 2020. However, factors such as increased efforts such as public awareness campaigns, research, and joint partnerships between public and commercial institutions in the UAE and Kuwait, are expected to support the MEA market during the forecast period and help account for a considerable share in the global market during the forecast period. In addition, the rising use of improved diagnostic techniques and technologies and strategic activities such as collaborations and agreements by key players are accelerating market expansion in this region.

KEY MARKET PLAYERS:

Some of the key players operating in the market are Transasia Biomedicals ltd., Abbott Laboratories, Alere, Inc., Arkray, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare, and Trinity Biotech plc.